K200168 is an FDA 510(k) clearance for the Dermapose Access. This device is classified as a System, Suction, Lipoplasty For Removal (Class II - Special Controls, product code QPB).
Submitted by Puregraft, LLC (Solana Beach, US). The FDA issued a Cleared decision on April 22, 2020, 90 days after receiving the submission on January 23, 2020.
This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.5040. A Suction Lipoplasty System Is A Device Intended For The Removal Of Adipose Tissue For Purposes Of Aesthetic Body Contouring.